Populism, Rights, and Rule of Law in the Body
Health is political: anti-vax rallies, mask wars, and online disinfo. The EU ties funds to rule-of-law in Hungary and Poland, auditing COVID spending. Abortion access and sex education debates test the limits of EU competence.
Episode Narrative
In the heart of Europe, an evolution is taking place within the complex tapestry of healthcare, rights, and governance. This narrative unfolds against a backdrop of transformative events that span decades, bringing to light the shadows of populism, the quest for individual rights, and the enduring struggle for the rule of law. As we delve into this story, we will witness how urgent health needs ripple through society, shaping policies and revealing the deep connections between health, governance, and human dignity.
Let's begin our journey in the not-so-distant future, in the year 2025. The sun may rise on a day when 17 of the 27 member states of the European Union recommend the herpes zoster vaccination for their citizens. This immunization effort predominantly targets older adults and high-risk groups. Yet, amidst this initiative lies a disheartening reality: only seven of those countries fully subsidize the vaccine under their national healthcare systems. The recent withdrawal of the live-attenuated Zostavax vaccine marks a pivotal moment, underscoring the urgent need for harmonized adult immunization strategies across the EU. Health is political, and the political landscape influences who gets access to vital healthcare.
Stepping back to the late 20th century, we find that the prevalence of Type 1 diabetes mellitus in the EU nearly doubled between 1990 and 2021. This sobering statistic reveals a profound and rising disease burden amid world-shaping medical advances. Transitioning from 1.3 million cases to almost 2.9 million, the figures reflect more than just numbers; they embody human lives intertwined in a web of suffering and resilience. Cyprus, Ireland, and Greece emerge as the nations with the steepest climbs in the prevalence of this disease, illustrating the infallible truth that health disparities know no borders.
Amidst these health challenges, we also bear witness to profound human movement. From 2010 to 2025, armed conflicts, economic inequalities, demographic shifts, and labor market demands frame the migration landscape across the EU. While the EU strengthens asylum policies and external border controls, the internal rifts regarding the distribution of refugees and solidarity grow ever wider. The plight of refugees reveals much about our shared humanity, demanding that we ask ourselves: Who are we if we fail to care for those in need?
As we navigate through this landscape, we must confront the political environments that shape these realities. The dawn of the European Health Union initiative between 2020 and 2025 has been sparked by lessons learned amidst the chaos of the COVID-19 pandemic. This initiative expands the mandates of both the European Medicines Agency and the European Centre for Disease Prevention and Control. Moreover, it ushers in the creation of the Health Emergency Preparedness and Response Authority, aiming to reformulate how the EU addresses health security.
While the pandemic exposed vulnerabilities within health systems, it also reignited discussions on the essential need for solidarity among member states. Uneven access to preventative care vividly illustrates how health inequalities can fracture unity, particularly brought to the forefront by the pandemic's harsh light. Calls for a true European Health Union echo across the continent as nations grapple with the implications of interconnectedness in health; after all, citizens feel the weight of their governments' decisions on their very bodies.
Since the early 1990s, EU health policy has transitioned from a limited scope toward a more integrated approach, deftly maneuvering between national sovereignty and the necessity of EU-level coordination. The complexity of these debates reveals the tensions inherent in balancing personal rights with the overarching needs of public health. As borders become less daunting thanks to modern agreements, the question remains: how do we ensure that individual rights are protected while pursuing collective health objectives?
This journey through time also leads us to observe how healthcare systems in formerly Eastern Bloc countries have evolved. Countries like Poland and Estonia have ambitiously sought to replace once-specialist-driven systems with models that prioritize family medicine and multidisciplinary care. Supported by EU structural funds and financial incentives, these reforms aim to reinforce access. Yet, challenges persist. Workforce shortages and gaps in preventive care illuminate how even well-intentioned reforms can stumble under practical burdens.
From 2014 to 2020, the EU’s Cohesion Policy sought to remedy disparities in healthcare access. The aim was to uplift less advantaged regions, particularly within the Visegrad Group countries. Structural funds flowed to build infrastructure and improve services, yet merely pouring money into systems is a hollow solution without addressing underlying inequities. The language of health can become a heavy burden, echoing the historical context of inequality among different regions.
Turning our gaze back to 2024, we encounter another chapter of reform; the EU’s pharmaceutical regulations aim to harmonize clinical evaluation processes. As countries face complex administrative landscapes and the diversity of national healthcare systems, delays in implementation and access threaten to overshadow the intent. In the quest for better healthcare, the EU grapples with the challenge of ensuring equitable access to medicines while navigating bureaucratic intricacies.
Against this backdrop of reform and challenge, we hear from the citizens themselves. Public opinion in Spain reflects a limited yet gradually growing awareness of EU consular protections in health emergencies abroad. The preference for national authority and skepticism of EU governance embodies a broader challenge facing health governance legitimacy. Such perceptions reveal the roots of populism, where distrust in institutions can undermine solidarity and hinder effective policy responses.
The journey doesn't end here. It is also a story of progress. Since 1991, we have seen a heavy emphasis placed on digital health and mental health programs, with countries like Ireland, Germany, and Sweden making strides in reducing unmet medical needs. While climate-resilient and equity-focused interventions show promise, their variable implementation raises questions about consistency and long-term impact. Still, it is a step toward recognizing health as a multi-faceted human right.
Trust and solidarity have emerged as the bedrock of EU health governance, especially as we venture into a post-pandemic era. The European Health Union seeks to enhance risk-sharing and universal access, advocating for policies that reduce health disparities. In a climate marked by distrust, will the EU be able to restore faith in the collective body of governance?
As we look to the future, we find that the EU’s global health strategy, updated in 2022, prioritizes universal health coverage and pandemic preparedness. The EU is not only confronting its internal challenges but is also expanding its role in global health diplomacy. This reflects a recognition that health transcends national boundaries and requires cooperation across spheres, echoing the sentiment that we are all interconnected in this fragile tapestry of existence.
The narrative of cross-border healthcare rights since the early ’90s tells a profound tale of mobility amid the convergence of EU law and national social protections. It recognizes healthcare as a service, allowing citizens to traverse borders in search of treatment — yet introduces the complexities that arise from this increased mobility. Each interaction complicates the relationship between individual rights and national systems, demanding careful navigation through the complexities of governance.
We also recognize the need for resilience within health systems, a lesson painfully learned from the ravages of COVID-19. The focus on infrastructure modernization and workforce development aims to reconcile past failures with future needs. As the EU seeks to improve integration between primary care and hospital services, the question remains: Can we learn from history to forge a healthier future for all?
The convergence of health expenditures among EU countries presents a mixed tableau, where public and private spending is swayed by the weight of aging populations and technological advancements. Fiscal sustainability and equity are at risk, reminding us that the journey toward a healthier society requires robust political will.
Finally, the importance of personalized medicine rises to the forefront of EU health research. Initiatives aimed at integrating genomics into healthcare promise improvements in outcomes and efficiency, yet they raise ethical questions about access and equality. As we venture into uncharted territories of medical innovation, it is imperative to pause and reflect on whose interests are served in a rapidly evolving health landscape.
In the end, this multifaceted narrative is shaped by the interplay between health rights, governance, and populism. It challenges us to question the very framework of our societies. How do we foster solidarity while ensuring individual dignity? The answer lies in our collective commitment to a vision that transcends borders — a vision that places human health and rights at its core. Only then can we truly embrace the ideals of justice and equity in health for generations to come.
In the face of immense complexity, the story of health and governance prompts us to look in the mirror of our own making. Are we defined by division, or can we emerge together as one, forging pathways of solidarity, rights, and dignity for every individual? The journey is ongoing, and the choices we make today will echo long into the future.
Highlights
- 2025: Herpes zoster (shingles) vaccination is recommended in 17 of the 27 EU member states, targeting mainly older adults (≥50 to ≥65 years) and at-risk groups from age 18; only 7 countries fully cover the vaccine cost under national healthcare systems. The withdrawal of the live-attenuated Zostavax vaccine in June 2025 highlights the need for harmonized adult immunization strategies across the EU.
- 1990-2021: The prevalence of Type 1 diabetes mellitus (T1DM) in the EU nearly doubled from 1.3 million to 2.9 million, with disability-adjusted life years (DALYs) increasing and deaths decreasing. Cyprus, Ireland, and Greece showed the highest annual percentage increases in T1DM prevalence and incidence, reflecting rising disease burden despite medical advances.
- 2010-2025: Migration in the EU has been shaped by armed conflicts, economic inequality, demographic aging, and labor market needs. The EU strengthened asylum policies, external border controls, and cooperation with origin/transit countries, but internal disagreements on refugee distribution and solidarity persist.
- 2024: The EU’s mandatory climate disclosure policy, under the Corporate Sustainability Reporting Directive, led to decreased financial market volatility in the EU, enhancing market stability and transparency, contrasting with no significant spillover effects in China. This reflects the EU’s leadership in integrating health and environmental sustainability.
- Since 2018: The Health System and Policy Monitor (HSPM) network tracked 337 health reforms in 31 mainly EU countries, showing increasing interaction between primary health care and care coordination, with reforms focusing on quality, access, and system resilience.
- 2020-2025: The European Health Union (EHU) initiative, accelerated by the COVID-19 pandemic, expanded mandates of the European Medicines Agency and European Centre for Disease Prevention and Control, created the Health Emergency Preparedness and Response Authority (HERA), and aimed to strengthen EU health security and crisis response.
- 2024: The EU faces persistent health inequalities revealed by COVID-19, with uneven prevention and care access between and within member states. The pandemic exposed health system vulnerabilities, prompting calls for a true European Health Union to ensure solidarity and resilience.
- 1991-2025: EU health policy has evolved from a limited mandate to a more integrated approach balancing national sovereignty and EU-level coordination, with ongoing debates on subsidiarity and the scope of EU intervention in health systems.
- 1990s-present: Primary health care reforms in former Eastern Bloc countries like Poland and Estonia have aimed to shift from specialist-dominated systems to family medicine and multidisciplinary care, supported by EU structural funds and financial incentives, though challenges remain in workforce shortages and preventive care.
- 2014-2020: EU Cohesion Policy targeted reducing regional disparities in health care access and quality, especially in less-favored regions such as the Visegrad Group countries, using structural funds to improve infrastructure and services.
Sources
- https://www.mdpi.com/2076-393X/13/10/1073
- https://academic.oup.com/jes/article/doi/10.1210/jendso/bvaf149.919/8298032
- http://visnyk-pravo.uzhnu.edu.ua/article/view/324887
- https://www.ewadirect.com/proceedings/aemps/article/view/27659
- http://economicspace.pgasa.dp.ua/article/view/335263
- https://ibn.idsi.md/sites/default/files/imag_file/54-57_64.pdf
- http://journal-app.uzhnu.edu.ua/article/view/328236
- https://academic.oup.com/eurpub/article/doi/10.1093/eurpub/ckaf161.1127/8303163
- https://revistes.uab.cat/quadernsiee/article/view/v5-n1-biten-fernandez
- https://link.springer.com/10.1007/s41669-024-00556-w